Abstract 4370057: Comparison of non-calcified to calcified plaque ratio versus noncalcified plaque burden to predict adverse cardiovascular outcomes in the CONFIRM2 registry

D Dinesh Kalra (University of Louisville, Louisville, Kentucky, United States) A Alexander van Rosendael (Leiden University Medical Center, Leiden, Netherlands) J Jisuk Park (Cleerly, Inc., Durham, North Carolina, United States) A Andrew Oehler (Allegheny Health Network, Pittsburgh, Pennsylvania, United States) J Jeroen Bax (Leiden University Medical Center, Leiden, Netherlands) M Matthew Budoff (The Lundquist Institute, Torrance, California, United States) H Himanshu Gupta M Maros Ferencik G George Wesbey (Scripps Clinic, La Jolla, California, United States) N Nick Nurmohamed (Amsterdam UMC, Amsterdam, Netherlands) R Rebecca Fisher C Christoph Gräni G Gudrun Feuchtner (Medical University Innsbruck, Innsbruck, Austria) A Amro Alsaid (Baylor Scott and White - The Heart Hospitals, Plano, Texas, United States) R Ronald Karlsberg (Cedars Sinai Heart Institute CVRF, Beverly Hills, California, United States) R Ronny Buechel (University Hospital Zurich, Zurich, Switzerland) V Vasileios Kamperidis (Aristotle University of Thessaloniki, Thessaloniki, Greece) M Mirvat Alasnag D Daniele Andreini (CENTRO CARDIOLOGICO MONZINO, Milan, Italy) S Sabha Bhatti (National Institute of Cardiovascular Diseases Karachi Pakistan, Karachi, Pakistan) S Stephen Bloom (Midwest Heart and Vascular, Overland Park, Kansas, United States) B Borek Foldyna K Kelley Branch (UNIVERSITY OF WASHINGTON, Seattle, Washington, United States) F Filippo Cademartiri (IRCCS SYNLAB SDN, Naples, Italy) R Rhanderson Cardoso (Brigham and Womens Hospital, Boston, Massachusetts, United States) V Victor Cheng (Minneapolis Heart Institute, Minneapolis, Minnesota, United States) G Geoffrey Cho (UCLA, Los Angeles, California, United States) A Andrew Choi (The GW Medical Faculty Associates, Washiton, District of Columbia, United States) C Carlo De Cecco (Emory University, Atlanta, Georgia, United States) R Roderick Deano (University of Wisconsin, Madison, Wisconsin, United States) D David German (OHSU, Portland, Oregon, United States) M Martin Hadamitzky O Omar Khalique (St. Francis Hospital and Heart Center, Roslyn, New York, United States) P Paul Knaapen (Amsterdam UMC, Amsterdam, Netherlands) M Mouaz Al-Mallah (Houston Methodist DeBakey Heart&Vascular Center, Houston, Texas, United States) J Jim Mills (West Virginia University, Morgantown, West Virginia, United States) P Prashant Nagpal (University of Wisconsin-Madison, Madison, Wisconsin, United States) R Rine Nakanishi (Toho University Medical Center, Tokyo, Japan) G Gianluca Pontone A Amit Patel V Venkateshwar Polsani (Piedmont Heart Institute, Atlanta, Georgia, United States) A Amit Pursnani (NorthShore, Chicago, Illinois, United States) S Saima Mushtaq V Vasvi Singh (Midwest Heart and Vascular, Overland Park, Kansas, United States) M Marly van Assen C Cristiane De Carvalho Singulane (University of Virginia, Charlottesville, Virginia, United States) I Ibrahim Danad (Amsterdam UMC, Amsterdam, Netherlands)

Abstract

Background: While the burden and morphological features of coronary atherosclerosis are both important drivers of major adverse cardiovascular events (MACE), there remains uncertainty about which plaque type is more likely to predispose to MACE i.e. noncalcified plaque (NCP) or calcified plaque (CP). Research question: Does NCP:CP ratio or NCP volume influence MACE in patients from the CONFIRM2 registry, an international, observational cohort study? Methods: Symptomatic patients without prior MI/revascularization referred to coronary CTA for clinical indications were included. CP and NCP volumes were determined using artificial intelligence-facilitated coronary CT (AI-QCT). The primary endpoint (MACE) was a composite of all-cause death, myocardial infarction, stroke, heart failure, late revascularization, and hospitalization for unstable angina. Results: Of the 3,551 patients (median age 59 years; 49.5% women), data were available for 3,301. A total of 250 patients with no identifiable plaque were excluded from the analysis. MACE occurred in 4.7% of patients (median f/u 51 months). Hypertension, hyperlipidemia, and smoking were present in 54.3%, 48.1%, and 14%. Statin use in 67.3%, CACS = 0 in 41.7%. 91% had NCP <250 mm 3 , 8.4% 250-750 mm 3 and 0.7% >750 mm 3 . MACE rates for tertiles of NCP:CP ratio were statistically significant (Panel A; p=0.0003): 1 st tertile (Mean NCP:CP ratio of 46%; n=1100 patients; median NCP volume = 85.6 mm 3 ; MACE rate of 5.6%); 2 nd tertile (NCP:CP 81%; n=1101; NCPvol. = 67.6 mm 3 ; 6.6%); 3 rd tertile (NCP:CP 99%; n=1100; NCPvol. = 22.3 mm 3 ; 2.9%). However, in a multivariable Cox proportional hazards model adjusted for sex and age, when adjusting also for NCP volume, the NCP:CP tertile ratio did not remain a significant predictor of MACE, p=0.115 (Model#3, Panel B). Only 9 patients had predominant CP (NCP:CP ratio<10%) while the majority had predominant NCP. Conclusions: The main driver of incident MACE was the noncalcified plaque volume (NCP) rather than the NCP:CP ratio. More data with a larger cohort of patients with relatively more CP is needed to evaluate the role of individual features of partially calcified plaques such as spotty calcification to assess if they are better predictors of MACE or whether NCP volume alone is sufficient.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (47)

D

Dinesh Kalra

University of Louisville, Louisville, Kentucky, United States

A

Alexander van Rosendael

Leiden University Medical Center, Leiden, Netherlands

J

Jisuk Park

Cleerly, Inc., Durham, North Carolina, United States

A

Andrew Oehler

Allegheny Health Network, Pittsburgh, Pennsylvania, United States

J

Jeroen Bax

Leiden University Medical Center, Leiden, Netherlands

M

Matthew Budoff

The Lundquist Institute, Torrance, California, United States

H

Himanshu Gupta

M

Maros Ferencik

G

George Wesbey

Scripps Clinic, La Jolla, California, United States

N

Nick Nurmohamed

Amsterdam UMC, Amsterdam, Netherlands

R

Rebecca Fisher

C

Christoph Gräni

G

Gudrun Feuchtner

Medical University Innsbruck, Innsbruck, Austria

A

Amro Alsaid

Baylor Scott and White - The Heart Hospitals, Plano, Texas, United States

R

Ronald Karlsberg

Cedars Sinai Heart Institute CVRF, Beverly Hills, California, United States

R

Ronny Buechel

University Hospital Zurich, Zurich, Switzerland

V

Vasileios Kamperidis

Aristotle University of Thessaloniki, Thessaloniki, Greece

M

Mirvat Alasnag

D

Daniele Andreini

CENTRO CARDIOLOGICO MONZINO, Milan, Italy

S

Sabha Bhatti

National Institute of Cardiovascular Diseases Karachi Pakistan, Karachi, Pakistan

S

Stephen Bloom

Midwest Heart and Vascular, Overland Park, Kansas, United States

B

Borek Foldyna

K

Kelley Branch

UNIVERSITY OF WASHINGTON, Seattle, Washington, United States

F

Filippo Cademartiri

IRCCS SYNLAB SDN, Naples, Italy

R

Rhanderson Cardoso

Brigham and Womens Hospital, Boston, Massachusetts, United States

V

Victor Cheng

Minneapolis Heart Institute, Minneapolis, Minnesota, United States

G

Geoffrey Cho

UCLA, Los Angeles, California, United States

A

Andrew Choi

The GW Medical Faculty Associates, Washiton, District of Columbia, United States

C

Carlo De Cecco

Emory University, Atlanta, Georgia, United States

R

Roderick Deano

University of Wisconsin, Madison, Wisconsin, United States

D

David German

OHSU, Portland, Oregon, United States

M

Martin Hadamitzky

O

Omar Khalique

St. Francis Hospital and Heart Center, Roslyn, New York, United States

P

Paul Knaapen

Amsterdam UMC, Amsterdam, Netherlands

M

Mouaz Al-Mallah

Houston Methodist DeBakey Heart&Vascular Center, Houston, Texas, United States

J

Jim Mills

West Virginia University, Morgantown, West Virginia, United States

P

Prashant Nagpal

University of Wisconsin-Madison, Madison, Wisconsin, United States

R

Rine Nakanishi

Toho University Medical Center, Tokyo, Japan

G

Gianluca Pontone

A

Amit Patel

V

Venkateshwar Polsani

Piedmont Heart Institute, Atlanta, Georgia, United States

A

Amit Pursnani

NorthShore, Chicago, Illinois, United States

S

Saima Mushtaq

V

Vasvi Singh

Midwest Heart and Vascular, Overland Park, Kansas, United States

M

Marly van Assen

C

Cristiane De Carvalho Singulane

University of Virginia, Charlottesville, Virginia, United States

I

Ibrahim Danad

Amsterdam UMC, Amsterdam, Netherlands